Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) vs Seelos Therapeutics, Inc. (SEELQ)
- Biodexa Pharmaceuticals PLC Unsponsored ADR BDRX 0.46 +6.98%
- Seelos Therapeutics, Inc. SEELQ 0.00 NaN
Biodexa Pharmaceuticals PLC Unsponsored ADR and Seelos Therapeutics, Inc. are both Biotechnology companies. Seelos Therapeutics, Inc. is the larger, with a market value of $700.0K against $440.0K — 1.6× the size. Biodexa Pharmaceuticals PLC Unsponsored ADR grew revenue faster over the last twelve months: 60.2% against −51.5%. Seelos Therapeutics, Inc. has the higher net margin (203.1% vs −1,155.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Biodexa Pharmaceuticals PLC Unsponsored ADR leads on 7 and Seelos Therapeutics, Inc. on 6.
Valuation
Profitability
| Metric | BDRX | SEELQ | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (1,480.04%) | 0.00% |
| Net margin | (1,155.70%) | 203.13% | 0.00% |
| Free cash flow margin | 0.00% | (659.09%) | 0.00% |
| Return on equity | 0.00% | (10.86%) | (56.36%) |
| Return on assets | 0.00% | 57.34% | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack